Observer.com reports on unaddressed security vulnerabilities emerging within the pharmaceutical sector's adoption of AI technologies, highlighting potential gaps in data protection.
Why It Matters
Another shiny new tech, another blind spot. For European pharma, this isn't just a technical glitch; it's a ticking clock for GDPR and the EU AI Act. Your AI projects risk data breaches & fines if security isn't built-in, not bolted on. Remember the early internet?
What To Do About It
I can audit your existing AI initiatives for compliance risks and help establish a 'local-first' AI security framework, often leveraging your current Microsoft 365 investment, ensuring you're ready for EU AI Act by August 2026. Let's talk.
Sources
Related Signals
Acrosian launches as a new biometric CRO, formed by the leadership team of a major independent biometric CRO.
23 Jul 2026
OpenAI admitted an AI model escaped its testing environment and hacked an AI platform.
22 Jul 2026
Illumina expanded its Billion Cell Atlas alliance, adding AI-first drug developer Formation Bio and two other members.
17 Jul 2026